Literature DB >> 12711340

Evaluating the binding affinities of NF-kappaB p50 homodimer to the wild-type and single-nucleotide mutant Ig-kappaB sites by the unimolecular dsDNA microarray.

Jin K Wang1, Tong X Li, Yun F Bai, Zu H Lu.   

Abstract

This study investigated the binding affinities of NF-kappaB p50 homodimer to the wild-type and single-nucleotide mutant Ig-kappaB sites by the unimolecular dsDNA microarray which was fabricated with a novel scheme. The importance of each nucleotide of Ig-kappaB site for the sequence-specific p50p50/Ig-kappaB interaction was thus evaluated. The results demonstrate that the nucleotides at different positions contribute differently to the p50p50/Ig-kappaB binding interaction. The G(1), G(2), and C(10) are most important for p50p50/Ig-kappaB binding interaction and determine the specificity of p50p50/Ig-kappaB interaction, which replacements with any other nucleotide could result in the similarly greatest binding affinity losses. Comparatively, the G(3), A(4), T(8), and C(9) are less important for p50p50/Ig-kappaB interaction and regulate the binding affinity, which substitutions with the variant nucleotide could change the binding affinity differently. The C(5) is least important for p50p50/Ig-kappaB interaction, the randomized nucleotide exchange of which little affects on p50p50/Ig-kappaB binding affinity. Among all possible single-nucleotide mutants, the T(8) to C mutation could strengthen p50p50/Ig-kappaB interaction. The T(7) acts differently from its symmetric C(5) and the axial T(6) is necessary for high-affinity p50p50/Ig-kappaB interaction. The unimolecular dsDNA microarray provides a reliable method for exploring the binding affinities of DNA-binding proteins with a larger number of DNA targets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711340     DOI: 10.1016/s0003-2697(03)00049-6

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  Quantitative high-throughput analysis of transcription factor binding specificities.

Authors:  Jane Linnell; Richard Mott; Simon Field; Dominic P Kwiatkowski; Jiannis Ragoussis; Irina A Udalova
Journal:  Nucleic Acids Res       Date:  2004-02-27       Impact factor: 16.971

2.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

3.  Development of a microscopic platform for real-time monitoring of biomolecular interactions.

Authors:  Yasuhiro Sasuga; Tomomi Tani; Masahito Hayashi; Hisashi Yamakawa; Osamu Ohara; Yoshie Harada
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

4.  Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres.

Authors:  Wei Dai; Jian Wu; Danyang Wang; Jinke Wang
Journal:  Gene Ther       Date:  2020-02-07       Impact factor: 5.250

5.  HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.

Authors:  Joshua N Leonard; Priya S Shah; John C Burnett; David V Schaffer
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

6.  Creating PWMs of transcription factors using 3D structure-based computation of protein-DNA free binding energies.

Authors:  Denitsa Alamanova; Philip Stegmaier; Alexander Kel
Journal:  BMC Bioinformatics       Date:  2010-05-03       Impact factor: 3.169

7.  Single-nucleotide mutation matrix: a new model for predicting the NF-κB DNA binding sites.

Authors:  Wenxin Du; Jing Gao; Tingting Wang; Jinke Wang
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

8.  Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors.

Authors:  Michael F Berger; Martha L Bulyk
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

9.  Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate.

Authors:  Giordana Feriotto; Alessia Finotti; Pompeo Volpe; Susan Treves; Stefano Ferrari; Cecilia Angelelli; Francesco Zorzato; Roberto Gambari
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

10.  Atypical IκB proteins - nuclear modulators of NF-κB signaling.

Authors:  Marc Schuster; Michaela Annemann; Carlos Plaza-Sirvent; Ingo Schmitz
Journal:  Cell Commun Signal       Date:  2013-04-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.